Showing posts with label truvada. Show all posts
Showing posts with label truvada. Show all posts

Monday 14 April 2014

Doctors Recommend A New Drug For The Prevention Of HIV Infection

Doctors Recommend A New Drug For The Prevention Of HIV Infection.
Should bodies in hazard of contracting HIV because they have risky sex rent a pill to prevent infection, or will the medication encourage them to take even more sexual risks? After years of deliberation on this question, a new international study suggests the medication doesn't lead relatives to stop using condoms or have more sex with more people. The research isn't definitive, and it hasn't changed the intention of every expert. But one of the study's co-authors said the findings support the drug's use as a method to prevent infection with HIV, the virus that causes AIDS.

And "People may have more partners or stop using condoms, but as well as we can tell, it's not because of taking the cure-all to prevent HIV infection ," said study co-author Dr Robert Grant, a elder investigator with the Gladstone Institute of Virology and Immunology in San Francisco. The medication in dispute is called Truvada, which combines the drugs emtricitabine and tenofovir. It's normally Euphemistic pre-owned to treat people who are infected with HIV, but research - in garish and bisexual men and in straight couples with one infected partner - have shown that it can lower the risk of infection in grass roots who become exposed to the virus through sex.

However, it does not eliminate the risk of infection. The US Food and Drug Administration approved the medicine for prevention purposes in 2012. Few people seem to be taking it for control purposes, however. Its manufacturer, Gilead, has disclosed that about 1700 people are taking the drug for that sense in the United States, Grant said. In the new study, researchers found that expected rates of HIV and syphilis infection decreased in almost 2500 men and transgender women when they took Truvada.

The turn over participants, who all faced lofty risk of HIV infection, were recruited in Peru, Ecuador, South Africa, Brazil, Thailand and the United States. Some of the participants took Truvada while others took an idle placebo. Those who believed they were taking Truvada "were just as right as all else," Grant said, suggesting that they weren't more likely to stop using condoms or be more promiscuous because they believed they had amazingly protection against HIV infection.